Virbac SA

VRBCF•United States

Healthcare United States Drug Manufacturers - General

Need professional-grade analysis? Visit stockanalysis.com

$384.75

+0.00%

End of day

Market Cap

$3.22B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

44.00%

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sharpe	—	—	—	1.36	1.46	—	1.42
Ulcer	—	—	—	0.00	0.00	—	0.00

Virbac SA (VRBCF) Price Performance

Virbac SA (VRBCF) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at $384.75.

Over the past year, VRBCF has traded between a low of $320.96 and a high of $384.75. The stock has gained 19.9% over this period. It is currently 19.9% above its 52-week low.

Virbac SA has a market capitalization of $3.22B and a dividend yield of 44.00%.

About Virbac SA

Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.

Company Info

Sector: Healthcare
Industry: Drug Manufacturers - General
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): $1.46B
EBITDA: $290.25M
Profit Margin: 10.30%
EPS (TTM): 20.81
Book Value: 146.18

Technical Indicators

52 Week High: $431.80
52 Week Low: $320.96
50 Day MA: $360.73
200 Day MA: $349.56
Beta: 0.85

Valuation

Trailing P/E: 18.49
Forward P/E: N/A
Price/Sales: 2.20
Price/Book: 2.63
Enterprise Value: $3.22B